These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27936526)

  • 1. Diclofenac systemic bioavailability of a topical 1% diclofenac + 3% menthol combination gel vs. an oral diclofenac tablet in healthy volunteers: a randomized, open-label, crossover study
.
    Moreira SA; Liu DJ
    Int J Clin Pharmacol Ther; 2017 Apr; 55(4):368-372. PubMed ID: 27936526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Irritation and Sensitization Potential of Fixed-Dose Combination of Diclofenac 1% and Menthol 3% Topical Gel: Results of Two Phase I Patch Studies.
    Liu DJ; Collaku A; Dosik JS
    Drug Res (Stuttg); 2017 Feb; 67(2):119-126. PubMed ID: 27887033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers.
    Kienzler JL; Gold M; Nollevaux F
    J Clin Pharmacol; 2010 Jan; 50(1):50-61. PubMed ID: 19841157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects.
    Brunner M; Davies D; Martin W; Leuratti C; Lackner E; Müller M
    Br J Clin Pharmacol; 2011 Jun; 71(6):852-9. PubMed ID: 21241352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers.
    Holt RJ; Taiwo T; Kent JD
    Postgrad Med; 2015 Aug; 127(6):581-90. PubMed ID: 26077436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation.
    Brunner M; Dehghanyar P; Seigfried B; Martin W; Menke G; Müller M
    Br J Clin Pharmacol; 2005 Nov; 60(5):573-7. PubMed ID: 16236050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tramadol/Diclofenac Fixed-Dose Combination for Acute Pain Management: Bioavailability Assessment of a Generic Product.
    da Silva TM; Davanço MG; Meulman J; Vianna DRB; Costa F; Pacheco FBC; Carandina SAC; Issa E; Vespasiano CFP
    Clin Pharmacol Drug Dev; 2024 Aug; 13(8):907-914. PubMed ID: 38716761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofenac potassium 25 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative bioavailability study vs. diclofenac potassium 2 x 12.5 mg tablets.
    Armogida M; Gold M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):445-51. PubMed ID: 22677306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
    Desjardins PJ; Olugemo K; Solorio D; Young CL
    Clin Ther; 2015 Feb; 37(2):448-61. PubMed ID: 25499666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects.
    Mukherjee J; Das A; Chakrabarty US; Sahoo B; Sengupta P; Chatterjee B; Roy B; Pal TK
    Arzneimittelforschung; 2010; 60(8):506-9. PubMed ID: 20863007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema.
    Magnette JL; Kienzler JL; Sallin D; Ménart C; Nollevaux F; Knops A
    Eur J Clin Pharmacol; 2004 Oct; 60(8):591-4. PubMed ID: 15455182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diclofenac potassium 12.5 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative, bioavailability study versus diclofenac potassium 12.5 mg tablets.
    Kienzler JL; Gold M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):438-44. PubMed ID: 22677305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation.
    Bende G; Biswal S; Bhad P; Chen Y; Salunke A; Winter S; Wagner R; Sunkara G
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):76-82. PubMed ID: 27119581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of low-dose diclofenac potassium tablet formulations.
    Hinz B; Hug AM; Fotopoulos G; Gold MS
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):643-8. PubMed ID: 19825328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
    Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
    Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
    Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers.
    Iqbal Z; Khan A; Naz A; Khan JA; Khan GS
    Clin Drug Investig; 2009; 29(4):275-81. PubMed ID: 19301941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, open-label, 5-way crossover study to evaluate the pharmacokinetic/pharmacodynamic interaction between furosemide and the non-steroidal anti-inflammatory drugs diclofenac and ibuprofen in healthy volunteers.
    Paterson CA; Jacobs D; Rasmussen S; Youngberg SP; McGuinness N
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):477-90. PubMed ID: 21781648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.